1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AEFEB8292EA92EC365257C0F00448096
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/how-successful-companies-develop-high-value-competitive-intelligence-functions?opendocument
18
19opendocument
2034.226.234.20
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services

How Successful Companies Create and Develop a High-Value CI Function to Drive Better Business Decisions

ID: PSM-302


Features:

4 Info Graphics

25+ Data Graphics

300+ Metrics

50+ Narratives

5 Best Practices


Pages: 83


Published: Pre-2014


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

Buy this research as part of a

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
When done well, the Competitive Intelligence (CI) function helps companies make better decisions, anticipate threats, plan effectively in a rapidly changing market, and avoid corporate risk. But the non-traditional CI function is often undervalued in corporations, and CI leaders can find themselves struggling for attention and resources.


This report includes the findings from benchmarking the Competitive Intelligence function at 32 companies in the bio-pharmaceutical industry. It includes metrics and insights that CI leaders can use to evaluate their functions, increase the value of deliverables, and generate greater influence among their stakeholders.

Included in the report are benchmarks for the size, cost, scope, structure, tools, activities, and best practices that drive effectiveness in high-performing CI organizations. This report also identifies 10 Hallmarks of Competitive Intelligence Excellence and presents insights from interviews with veteran CI leaders on how to evolve the CI role from data gathering to providing strategic advice to decision makers.

Best Practices, LLC conducted this study to identify best practices and innovative methods for improving the strategic role and impact of the Competitive Intelligence function within the pharmaceutical and related industries. The study provides health care industry and CI leaders with metrics and insights they can use to increase the value of their function and generate greater influence within the corporation.


Industries Profiled:
Health Care; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Distribution; Science; Technology


Companies Profiled:
Abbott Nutrition; Amgen; AstraZeneca; Ariad; Bayer; Biocon; Boehringer Ingelheim; B Braun; Covidien; Daiichi-Sankyo; Dentsply; EMD Serono; Emergent; Ethicon; Ferring; GSK; Glenmark; Janssen; Jazz; Johnson & Johnson; McKesson; Medtronic; Merck; Novo Nordisk; Pfizer; Purdue; Sanofi Pasteur; Teva; Torrent; Upsher-Smith; Waters; Wyeth Nutrition/Nestle

Study Snapshot

Thirty-five Competitive Intelligence leaders from 32 companies in the healthcare industry participated in this benchmarking study. Participants represented small, midcap and large biopharmaceutical and medical device companies. Seventy percent work in U.S. locations. The Key topics in this study include:

  • Sources & Activities
    • Key primary & secondary research activities
    • When to use primary sources
    • CI source effectiveness
    • CI from social media & internal employees
    • Most effective activities
    • Percentage of work that is analysis
  • Budget & FTE Levels
  • Uses of Third Party Vendors
  • Top 5 CI Employee Skills
  • CI Evolution & Trends
  • Structure & Leadership
  • Best Practices & Lessons Learned

Sample Key Findings

Competitive Intelligence Trends
  • Use of Advisory Boards to Collect CI Is Shrinking: The use of Ad Boards is down significantly from previous BPLLC studies, where as many as 90% of respondents engaged them to gather intelligence. In this study, only 52% collect intelligence from advisory boards, and only 21% find them highly effective for primary research.

Competitive Intelligence Evolution & Influence
  • Experienced CI leaders stress the evolving nature of a new CI function: Their advice for short- and long-term success ranges from the physical proximity of CI to its internal customers, to desirable skill sets for employees, to optimal percentage of primary vs. secondary research.
Table of Contents

Executive Summary
    • Research Objectives & Methodology
    • Participating Companies
    • Key Findings & Insights
    • Hallmarks of Excellence in Competitive Intelligence
  • Section 1: Key CI Sources, Activities & Deliverables
    • 1A. Sources
    • 1B. Activities & Deliverables
  • Section 2: Use of Third Party CI Vendors
  • Section 3: CI Resources, Structure & Operations, Functional Evolution
    • 3A. Resources
    • 3B. Structure & Operations
    • 3C. Functional Evolution & Influence
  • Section 4: Best Practices & Lessons Learned